Circassia Group Plc
NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled N… Read more
Circassia Group Plc (CSSPF) - Total Assets
Latest total assets as of June 2025: $71.00 Million USD
Based on the latest financial reports, Circassia Group Plc (CSSPF) holds total assets worth $71.00 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Circassia Group Plc - Total Assets Trend (2013–2024)
This chart illustrates how Circassia Group Plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Circassia Group Plc - Asset Composition Analysis
Current Asset Composition (December 2024)
Circassia Group Plc's total assets of $71.00 Million consist of 30.9% current assets and 69.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 15.9% |
| Accounts Receivable | $4.60 Million | 6.7% |
| Inventory | $4.00 Million | 5.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $23.50 Million | 34.4% |
| Goodwill | $4.30 Million | 6.3% |
Asset Composition Trend (2013–2024)
This chart illustrates how Circassia Group Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Circassia Group Plc's current assets represent 30.9% of total assets in 2024, a decrease from 94.2% in 2013.
- Cash Position: Cash and equivalents constituted 15.9% of total assets in 2024, down from 62.0% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 40.0% of total assets, an increase from 4.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 34.4% of total assets.
Circassia Group Plc Competitors by Total Assets
Key competitors of Circassia Group Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Circassia Group Plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Circassia Group Plc generates 0.61x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Circassia Group Plc generates $5.41 in net profit.
Circassia Group Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.73 | 6.31 | 1.06 |
| Quick Ratio | 3.07 | 5.56 | 0.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $16.40 Million | $ 28.70 Million | $ 2.40 Million |
Circassia Group Plc - Advanced Valuation Insights
This section examines the relationship between Circassia Group Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.81 |
| Latest Market Cap to Assets Ratio | 3.57 |
| Asset Growth Rate (YoY) | -25.2% |
| Total Assets | $68.40 Million |
| Market Capitalization | $243.88 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Circassia Group Plc's assets at a significant premium ( 3.57x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Circassia Group Plc's assets decreased by 25.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Circassia Group Plc (2013–2024)
The table below shows the annual total assets of Circassia Group Plc from 2013 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $68.40 Million | -25.25% |
| 2023-12-31 | $91.50 Million | -7.11% |
| 2022-12-31 | $98.50 Million | +14.00% |
| 2021-12-31 | $86.40 Million | -16.20% |
| 2020-12-31 | $103.10 Million | -66.46% |
| 2018-12-31 | $307.40 Million | -23.61% |
| 2017-12-31 | $402.40 Million | +20.44% |
| 2016-12-31 | $334.10 Million | -31.70% |
| 2015-12-31 | $489.20 Million | +143.99% |
| 2014-12-31 | $200.50 Million | +427.19% |
| 2013-12-31 | $38.03 Million | -- |